Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-038155
Filing Date
2023-08-03
Accepted
2023-08-03 17:30:14
Documents
59
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nuvb-20230630.htm   iXBRL 10-Q 2957967
2 EX-31.1 nuvb-ex31_1.htm EX-31.1 21436
3 EX-31.2 nuvb-ex31_2.htm EX-31.2 21519
4 EX-32.1 nuvb-ex32_1.htm EX-32.1 11258
5 EX-32.2 nuvb-ex32_2.htm EX-32.2 9628
  Complete submission text file 0000950170-23-038155.txt   10637873

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nuvb-20230630_lab.xml EX-101.LAB 400487
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nuvb-20230630_pre.xml EX-101.PRE 299282
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nuvb-20230630_def.xml EX-101.DEF 176521
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nuvb-20230630.xsd EX-101.SCH 48648
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nuvb-20230630_cal.xml EX-101.CAL 50898
53 EXTRACTED XBRL INSTANCE DOCUMENT nuvb-20230630_htm.xml XML 2520410
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39351 | Film No.: 231141363
SIC: 2834 Pharmaceutical Preparations